Eva H. Brilstra

9.2k total citations
63 papers, 2.4k citations indexed

About

Eva H. Brilstra is a scholar working on Genetics, Psychiatry and Mental health and Neurology. According to data from OpenAlex, Eva H. Brilstra has authored 63 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Genetics, 27 papers in Psychiatry and Mental health and 16 papers in Neurology. Recurrent topics in Eva H. Brilstra's work include Epilepsy research and treatment (26 papers), Genomics and Rare Diseases (20 papers) and Genetics and Neurodevelopmental Disorders (16 papers). Eva H. Brilstra is often cited by papers focused on Epilepsy research and treatment (26 papers), Genomics and Rare Diseases (20 papers) and Genetics and Neurodevelopmental Disorders (16 papers). Eva H. Brilstra collaborates with scholars based in Netherlands, United States and Germany. Eva H. Brilstra's co-authors include Gabriël J.E. Rinkel, Ale Algra, Yolanda van der Graaf, Willem Jan J. van Rooij, Bobby P.C. Koeleman, J. van Gijn, Nienke E. Verbeek, Irene C. van der Schaaf, Floor E. Jansen and Kees P. J. Braun and has published in prestigious journals such as PLoS ONE, Neurology and PEDIATRICS.

In The Last Decade

Eva H. Brilstra

61 papers receiving 2.3k citations

Peers

Eva H. Brilstra

NEURO

PMH

GENET

PRM

Gerhard Kurlemann Germany

Mariasavina Severino Italy

Zühal Yapıcı Türkiye

Brahim Tabarki Saudi Arabia

J. Raymond Buncic Canada

Richard P. Morse United States

Byung Chan Lim South Korea

Paola Iannetti Italy

John H. Livingston United Kingdom

Simone Mandelstam Australia

Gerhard Kurlemann Germany

Eva H. Brilstra

341 ×0.3

NEURO

1.0k ×1.5

PMH

260 ×0.4

GENET

467 ×1.0

125 ×0.3

PRM

Citations per year, relative to Eva H. Brilstra Eva H. Brilstra (= 1×) peers Gerhard Kurlemann

Countries citing papers authored by Eva H. Brilstra

Since Specialization

Citations

This map shows the geographic impact of Eva H. Brilstra's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eva H. Brilstra with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eva H. Brilstra more than expected).

Fields of papers citing papers by Eva H. Brilstra

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eva H. Brilstra. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eva H. Brilstra. The network helps show where Eva H. Brilstra may publish in the future.

Co-authorship network of co-authors of Eva H. Brilstra

This figure shows the co-authorship network connecting the top 25 collaborators of Eva H. Brilstra. A scholar is included among the top collaborators of Eva H. Brilstra based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eva H. Brilstra. Eva H. Brilstra is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Brilstra, Eva H., Willem M. Otte, Ghislaine J. M. W. van Thiel, et al.. (2025). Blueprint for clinical N-of-1 strategies with off-label precision treatments in monogenic epilepsies. Orphanet Journal of Rare Diseases. 20(1). 309–309.

Koeleman, Bobby P.C., Eva H. Brilstra, Floor E. Jansen, et al.. (2024). Somatic variant analysis of resected brain tissue in epilepsy surgery patients. Epilepsia. 65(12). e209–e215. 6 indexed citations

Brilstra, Eva H., Willem M. Otte, J. Helen Cross, et al.. (2024). N‐of‐1 trials in epilepsy: A systematic review and lessons paving the way forward. Epilepsia. 65(11). 3119–3137. 7 indexed citations

Jansen, Floor E., Janneke Zinkstok, J. Verhoeven, et al.. (2024). Quality of life in SCN1A-related seizure disorders across the lifespan. Brain Communications. 6(5). fcae285–fcae285. 2 indexed citations

Peters, Mike J.L., Mariëlle H. Emmelot‐Vonk, Pim A. de Jong, et al.. (2024). The effects of etidronate on brain calcifications in Fahr’s disease or syndrome: rationale and design of the randomised, placebo-controlled, double-blind CALCIFADE trial. Orphanet Journal of Rare Diseases. 19(1). 49–49. 5 indexed citations

Tibben, Aad, et al.. (2024). Hope, but never expect? Comparing parents' pre‐ and post‐disclosure attitudes toward return of results from diagnostic exome sequencing for their child. Molecular Genetics & Genomic Medicine. 12(3). e2341–e2341. 1 indexed citations

Otte, Willem M., Floor E. Jansen, W. Boudewijn Gunning, et al.. (2024). Understanding neurodevelopmental trajectories and behavioral profiles in SCN1A-related epilepsy syndromes. Epilepsy & Behavior. 154. 109726–109726. 6 indexed citations

Jansen, Floor E., Charlotte W. Ockeloen, Marjan J. A. van Kempen, et al.. (2023). Epilepsy is an important feature of KBG syndrome associated with poorer developmental outcome. Epilepsia Open. 8(4). 1300–1313. 7 indexed citations

Milota, Megan, et al.. (2022). Challenging behavior in children and adolescents with Dravet syndrome: Exploring the lived experiences of parents. Epilepsy & Behavior. 138. 108978–108978. 17 indexed citations

10.

Hayman, Michael J., et al.. (2019). Punctate white-matter lesions in the full-term newborn: Underlying aetiology and outcome. European Journal of Paediatric Neurology. 23(2). 280–287. 27 indexed citations

11.

Lange, Iris, Patrick Rump, Rinze F. Neuteboom, et al.. (2017). Male patients affected by mosaic PCDH19 mutations: five new cases. Neurogenetics. 18(3). 147–153. 36 indexed citations

12.

Ribeiro, José Mendes, Pasquale Striano, Sarah Weckhuysen, et al.. (2017). A Distinctive Ictal Amplitude-Integrated Electroencephalography Pattern in Newborns with Neonatal Epilepsy Associated with <b><i>KCNQ2</i></b> Mutations. Neonatology. 112(4). 387–393. 38 indexed citations

13.

Boerma, Ragna S., Kees P. J. Braun, Mariëlle E.M. Swinkels, et al.. (2015). Remarkable Phenytoin Sensitivity in 4 Children with SCN8A-related Epilepsy: A Molecular Neuropharmacological Approach. Neurotherapeutics. 13(1). 192–197. 104 indexed citations

14.

Hussain, Sofia, Naomi Issler, Nicholas Lench, et al.. (2013). KCNJ10 Mutations Display Differential Sensitivity to Heteromerisation with KCNJ16. Nephron Physiology. 123(3-4). 7–14. 31 indexed citations

15.

Poot, Martin, Jasper J. van der Smagt, Eva H. Brilstra, & Thomas Bourgeron. (2011). Disentangling the Myriad Genomics of Complex Disorders, Specifically Focusing on Autism, Epilepsy, and Schizophrenia. Cytogenetic and Genome Research. 135(3-4). 228–240. 49 indexed citations

16.

Brilstra, Eva H., Gabriël J.E. Rinkel, Yolanda van der Graaf, et al.. (2003). Quality of Life after Treatment of Unruptured Intracranial Aneurysms by Neurosurgical Clipping or by Embolisation with Coils. Cerebrovascular Diseases. 17(1). 44–52. 99 indexed citations

17.

Brilstra, Eva H., Ale Algra, Gabriël J.E. Rinkel, Cornelis A. F. Tulleken, & J. van Gijn. (2002). Effectiveness of neurosurgical clip application in patients with aneurysmal subarachnoid hemorrhage. Journal of neurosurgery. 97(5). 1036–1041. 23 indexed citations

18.

Brilstra, Eva H. & Gabriël J.E. Rinkel. (2002). TREATMENT OF RUPTURED INTRACRANIAL ANEURYSMS BY EMBOLIZATION WITH CONTROLLED DETACHABLE COILS. The Neurologist. 8(1). 35–40. 11 indexed citations

19.

Brilstra, Eva H., Gabriël J.E. Rinkel, Catharina J.M. Klijn, et al.. (2002). Excimer laser—assisted bypass in aneurysm treatment: short-term outcomes. Journal of neurosurgery. 97(5). 1029–1035. 32 indexed citations

20.

Brilstra, Eva H., Jeannette W. Hop, & Gabriël J.E. Rinkel. (1997). Quality of life after perimesencephalic haemorrhage. Journal of Neurology Neurosurgery & Psychiatry. 63(3). 382–384. 58 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact